Literature DB >> 25658730

[NADPH oxidases, Nox: new isoenzymes family].

Minh Vu Chuong Nguyen1, Bernard Lardy2, Marie-Hélène Paclet2, Francis Rousset1, Sylvie Berthier1, Athan Baillet3, Laurent Grange3, Philippe Gaudin3, Françoise Morel1.   

Abstract

NADPH oxidases, Nox, are a family of isoenzymes, composed of seven members, whose sole function is to produce reactive oxygen species (ROS). Although Nox catalyze the same enzymatic reaction, they acquired from a common ancestor during evolution, specificities related to their tissue expression, subcellular localization, activation mechanisms and regulation. Their functions could vary depending on the pathophysiological state of the tissues. Indeed, ROS are not only bactericidal weapons in phagocytes but also essential cellular signaling molecules and their overproduction is involved in chronic diseases and diseases of aging. The understanding of the mechanisms involved in the function of Nox and the emergence of Nox inhibitors, require a thorough knowledge of their nature and structure. The objectives of this review are to highlight, in a structure/function approach, the main similar and differentiated properties shared by the human Nox isoenzymes.
© 2015 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25658730     DOI: 10.1051/medsci/20153101012

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

1.  Development of a caffeic acid-phthalimide hybrid compound for NADPH oxidase inhibition.

Authors:  Willian Henrique Dos Santos; Maurício Ikeda Yoguim; Regina Gomes Daré; Luiz Carlos da Silva-Filho; Sueli Oliveira Silva Lautenschlager; Valdecir Farias Ximenes
Journal:  RSC Adv       Date:  2021-05-18       Impact factor: 4.036

Review 2.  ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases.

Authors:  Pierpaola Davalli; Tijana Mitic; Andrea Caporali; Angela Lauriola; Domenico D'Arca
Journal:  Oxid Med Cell Longev       Date:  2016-05-10       Impact factor: 6.543

3.  5d, a novel analogue of 3-n-butylphthalide, decreases NADPH oxidase activity through the positive regulation of CK2 after ischemia/reperfusion injury.

Authors:  Jia Zhou; Yi-Hua Zhang; Hui-Zhu Song; Hui Ji; Xiao-Li Wang; Lei Wang; Jun Qian; Jing-Jing Ling; Feng-Feng Ping
Journal:  Oncotarget       Date:  2016-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.